首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于网络药理学与分子对接技术探讨白花蛇舌草治疗鼻咽癌的作用机制
引用本文:龙远雄,徐寅,邓桂明.基于网络药理学与分子对接技术探讨白花蛇舌草治疗鼻咽癌的作用机制[J].南华大学学报(医学版),2022(5):647-651.
作者姓名:龙远雄  徐寅  邓桂明
作者单位:湖南中医药大学第一附属医院,湖南省长沙市410007
基金项目:国家自然科学基金青年科学基金项目(81904176);湖南省教育厅科学研究优秀青年项目(21B0372);湖南省中医药科研计划青年项目(2021162);湖南省中医药科研计划重点项目(2021016);湖南中医药大学校级科研基金项目(2019XJJJ050、2019XJJJ025) 作者简介:龙远雄,硕士,助理研究员,研究方向为中医药信息化与标准化、中医临床数据分析与处理,E-mail为453170451@qq.com。通信作者邓桂明,博士,研究员,博士研究生导师,研究方向为临床中药学研究,E-mail为guimingd1004@163.com。
摘    要:目的基于网络药理学与分子对接技术探讨白花蛇舌草治疗鼻咽癌的作用机制。方法利用TCMSP、GeneCards数据库获取白花蛇舌草化合物、靶点与鼻咽癌靶点。将交集靶点导入STRING数据库构建靶点蛋白互作网络,筛选关键化合物与核心靶点,并进行分子对接。将交集靶点导入DAVID平台进行GO与KEGG富集分析。结果白花蛇舌草有效化合物6个,作用于鼻咽癌靶点49个,关键化合物4个,核心靶点12个。Degree值排前5的核心靶点与4个关键化合物体现较好结合性。白花蛇舌草治疗鼻咽癌主要影响163个生物学过程、63条通路。结论白花蛇舌草可能通过4个关键化合物作用于5个核心靶点影响生物学过程,调节关键通路来发挥治疗鼻咽癌的作用。

关 键 词:网络药理学    分子对接    白花蛇舌草    鼻咽癌  [
收稿时间:2022/4/10 0:00:00
修稿时间:2022/6/21 0:00:00

Mechanism of Hedyotis diffusa in the treatment of nasopharyngeal carcinoma based on network pharmacology and molecular docking technology
LONG Yuanxiong,XU Yin,DENG Guiming.Mechanism of Hedyotis diffusa in the treatment of nasopharyngeal carcinoma based on network pharmacology and molecular docking technology[J].Journal of Nanhua University(Medical Edition),2022(5):647-651.
Authors:LONG Yuanxiong  XU Yin  DENG Guiming
Institution:The First Hospital of Hunan University of Chinese Medicine, Changsha 410007, Hunan, China
Abstract:To explore the mechanism of Hedyotis diffusa in the treatment of nasopharyngeal carcinoma based on network pharmacology and molecular docking technology. MethodsThe compounds, targets and nasopharyngeal carcinoma targets of Hedyotis diffusa were obtained by TCMSP, GeneCards database. The intersecting targets were imported into STRING database to construct target protein interaction network, screen key compounds and core targets, and conduct molecular docking. Import the intersection target into DAVID platform for GO and KEGG enrichment analysis. ResultsThere were 6 effective compounds of Hedyotis diffusa, 49 targets for nasopharyngeal carcinoma, 4 key compounds and 12 core target genes. The top 5 core targets of degree value showed good binding with 4 key compounds. There are 163 biological processes and 63 pathways mainly affected by Hedyotis diffusa in the treatment of nasopharyngeal carcinoma. ConclusionHedyotis diffusa may exert its therapeutic effect on nasopharyngeal carcinoma by affecting biological processes and regulating key pathways through 4 key compounds acting on 5 core targets.
Keywords:network pharmacology  molecular docking  Hedyotis diffusa  nasopharyngeal carcinoma
点击此处可从《南华大学学报(医学版)》浏览原始摘要信息
点击此处可从《南华大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号